VMA21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.166800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.747800E-01
Normal-vs-Stage2
8.551800E-01
Normal-vs-Stage3
2.542600E-01
Normal-vs-Stage4
9.256400E-01
Stage1-vs-Stage2
3.041200E-01
Stage1-vs-Stage3
1.744760E-01
Stage1-vs-Stage4
5.951600E-01
Stage2-vs-Stage3
2.324600E-01
Stage2-vs-Stage4
9.103200E-01
Stage3-vs-Stage4
2.767600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.254800E-01
Normal-vs-AfricanAmerican
8.903600E-01
Normal-vs-Asian
6.096800E-01
Caucasian-vs-AfricanAmerican
7.427400E-01
Caucasian-vs-Asian
4.379200E-01
AfricanAmerican-vs-Asian
4.289000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.478400E-01
Normal-vs-Female
9.842200E-01
Male-vs-Female
4.180400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.780200E-01
Normal-vs-Age(41-60Yrs)
5.303400E-01
Normal-vs-Age(61-80Yrs)
6.213800E-01
Normal-vs-Age(81-100Yrs)
5.116000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.109800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.823500E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.791800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.4789000000085E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.848400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.503400E-01
Normal-vs-Daily Drinker
9.067000E-01
Normal-vs-Weekly Drinker
9.377600E-01
Normal-vs-Occasional Drinker
8.622800E-01
Normal-vs-Social Drinker
9.615000E-01
Non Drinker-vs-Daily Drinker
2.714800E-01
Non Drinker-vs-Weekly Drinker
4.492800E-01
Non Drinker-vs-Occasional Drinker
5.537500E-02
Non Drinker-vs-Social Drinker
1.549000E-01
Daily Drinker-vs-Weekly Drinker
9.786000E-01
Daily Drinker-vs-Occasional Drinker
6.099000E-01
Daily Drinker-vs-Social Drinker
7.648000E-01
Weekly Drinker-vs-Occasional Drinker
7.503000E-01
Weekly Drinker-vs-Social Drinker
8.322600E-01
Occasional Drinker-vs-Social Drinker
9.086000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.285800E-01
Normal-vs-Grade 2
8.124400E-01
Normal-vs-Grade 3
8.190600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.961600E-01
Grade 1-vs-Grade 3
8.287400E-01
Grade 1-vs-Grade 4
8.285800E-01
Grade 2-vs-Grade 3
7.748000E-01
Grade 2-vs-Grade 4
8.124400E-01
Grade 3-vs-Grade 4
8.190600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.831600E-01
Normal-vs-NonDiabetic
9.958800E-01
Diabetic-vs-NonDiabetic
2.178000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.705800E-01
Normal-vs-NoPancreatitis
8.418000E-01
Pancreatitis-vs-NoPancreatitis
7.354200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.238400E-01
Normal-vs-N1
8.725800E-01
N0-vs-N1
8.321600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.383800E-01
Normal-vs-TP53-NonMutant
9.757600E-01
TP53-Mutant-vs-TP53-NonMutant
1.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
